Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 37 | 44 | +7 |
| Shares | 16.5M | 16.8M | +333.1K (+2.0%) |
| Value | $116.7M | $50.0M | −$66.7M (−57.1%) |
New holders (9)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 714,285 | $2.12M | 0.65% |
| Point72 Asset Management, L.P. | 122,573 | $364.0K | 0.00% |
| Renaissance Technologies LLC | 67,800 | $201.0K | 0.00% |
| Driehaus Capital Management LLC | 35,100 | $104.0K | 0.00% |
| Barclays PLC | 15,352 | $46.0K | 0.00% |
| Amalgamated Bank | 2,079 | $6.00K | 0.00% |
| Amalgamated Financial Corp. | 2,079 | $6.00K | 0.00% |
| Cubist Systematic Strategies, LLC | 1,200 | $4.00K | 0.00% |
| Point72 Hong Kong Ltd | 71 | $0 | 0.00% |
Sold out (2)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 55,222 | $390.0K |
| UBS Group AG | 3,775 | $27.0K |